Kendall International
This article was originally published in The Gray Sheet
Executive Summary
Mansfield, Massachusetts-based firm signs manufacturing, supply and marketing agreement with the Institute of Molecular Biology, giving Kendall exclusive North American rights to distribute IMB's combined growth factors for treatment of chronic skin ulcers. Kendall also has taken a minority equity position in Worcester, Massachusetts-based IMB